Novo Nordisk | NVO - Capital De Préstamo

Precio De Mercado
37.97
Cambio Diario
0.55 1.47%
Mensual
-2.19%
Anual
-41.33%
Q2 Expectativa
35.64




Capital De Préstamo Cambio Fecha
ANI Pharmaceuticals USD 291.84M 5.84M 2025-12
Aurora Cannabis CAD 33.2M 1.79M 2025-12
Bausch Health Companies USD 20.62B 152M 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Canopy Growth CAD 224.99M 1.34M 2025-12
Drreddys Laboratories INR 129.19M 1.84M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
GlaxoSmithKline GBP 14.71B 186M 2025-12
Merck USD 39.97B 6B 2025-09
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Novartis USD 29.59B 5.35B 2025-12
Novo Nordisk DKK 118.94B 29.76B 2025-12
Novo Nordisk DKK 14.02B 224.49M 2025-09
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Phibro Animal Health USD 603.6M 5.92M 2025-12
Prestige Brands USD 1.05B 39.73M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Zoetis USD 9.04B 1.97B 2025-12